Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities    
Net loss $ (47,584,000) $ (48,503,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 2,291,000 2,771,000
Amortization 175,000 59,000
Share-based compensation expense 669,000 3,102,000
Unrealized foreign exchange (gains)/losses (396,000) 305,000
Accretion of available-for-sale debt securities (431,000) (23,000)
Other 33,000 (19,000)
Changes in operating assets and liabilities:    
(Increase)/decrease in receivables and other operating assets (1,582,000) 15,620,000
Increase in inventories (4,426,000)  
Decrease in payables and other current liabilities (13,011,000) (7,650,000)
Decrease in noncurrent assets 281,000  
Increase in borrowings and other non-current liabilities 606,000  
(Decrease)/increase in deferred revenue (3,217,000) 2,388,000
Net cash used in operating activities (66,592,000) (31,950,000)
Cash flows from investing activities    
Acquisition of property, plant and equipment (1,203,000) (102,000)
Acquisition of intangible assets   (256,000)
Maturity, redemption or sale of marketable securities 58,440,000  
Investment in marketable securities (16,090,000)  
Other 7,000  
Net cash provided by/(used in) investing activities 41,154,000 (358,000)
Cash flows from financing activities    
Repayment of borrowings (25,451,000)  
Proceeds from issuance of common stock from offerings, net of commissions and issuance costs 122,000 29,161,000
Proceeds from exercise of stock options 9,000 74,000
Net cash (used in)/provided by financing activities (25,320,000) 29,235,000
Effect of currency exchange rate changes on cash, cash equivalents and restricted cash 556,000 (416,000)
Net decrease in cash, cash equivalents and restricted cash (50,202,000) (3,489,000)
Cash, cash equivalents and restricted cash at start of period 93,206,000 147,017,000
Cash, cash equivalents and restricted cash at end of period $ 43,004,000 $ 143,528,000